CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 95,333 Value ($000) $2,742 Avg Close $30.88 Range $24.10 - $34.68

Q1 2025

Shares 26,458 Value ($000) $887 Avg Close $37.35 Range $31.65 - $53.55

Q4 2024

Shares 17,217 Value ($000) $880 Avg Close $55.95 Range $49.48 - $62.53

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	95,333	$2,742	$30.88	$24.10 - $34.68
Q1 2025	26,458	$887	$37.35	$31.65 - $53.55
Q4 2024	17,217	$880	$55.95	$49.48 - $62.53